Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03827213 · ClinicalTrials.gov registry record · Phase 2
Exparel Interscalene vs Indwelling Catheter
A Phase 2 study, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
NCT03827213 is a Phase 2 study that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT03827213, a Phase 2 study, was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
Study Summary
The investigators are comparing an indwelling catheter with intermediate duration local anesthetic to a single shot peripheral nerve block with long acting a local anesthetic (Exparel).
Interventions
- DRUG Exparel
- DEVICE Indwelling Interscalene Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-01-22 |
| Est. Completion | 2021-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03827213
The ClinicalTrials.gov registry entry for NCT03827213 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT03827213 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03827213 about?
NCT03827213 is a clinical study titled "Exparel Interscalene vs Indwelling Catheter". The investigators are comparing an indwelling catheter with intermediate duration local anesthetic to a single shot peripheral nerve block with long acting a local anesthetic (Exparel).
What is the current status of trial NCT03827213?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2019-01-22. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03827213?
The interventions under investigation include: Exparel (DRUG), Indwelling Interscalene Catheter (DEVICE).
Who is sponsoring clinical trial NCT03827213?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.